apl. Prof. Dr. Lucie Heinzerling

Medizinische Fakultät Department of Dermatology

Hyponatremia and Nephritis - Rare Side Effects of Checkpoint Inhibitors in Patients with metastatic Melanoma (2018) Mitzel-Rink H, Hassel J, Berking C, Gutzmer R, Heinzerling L, Majenka P, Meier F, et al. Conference contribution Influence of previous Radiotherapy on the Success of an immune-oncologic Therapy in metastatic Melanoma - a retrospective multicenter Study of ADO (2018) Knispel S, Zimmer L, Gutzmer R, Heinzerling L, Weishaupt C, Pfoehler C, Gesierich A, et al. Conference contribution Eosinophilic Fasciitis by Treatment with Checkpoint Inhibitors in metastatic Melanoma (2018) Toussaint F, Erdmann M, Moreira A, Kirchberger MC, Schuler G, Heinzerling L Conference contribution Expression of Senescence Markers - Is Predictive for Immune Therapy with Checkpoint Inhibitors? (2018) Moreira A, Gross S, Kirchberger MC, Erdmann M, Schuler G, Heinzerling L Conference contribution FV03 MEK Inhibitors improved the Survival of NRAS-mutated Melanoma Patients by using Checkpoint Inhibitors: Results of a retrospective, multicenter Analysis of 364 Patients (2018) Kirchberger MC, Ugurel S, Mangana J, Heppt M, Eigentler T, Berking C, Schadendorf D, et al. Conference contribution Fear of cancer progression in patients with stage IA malignant melanoma (2018) Wagner T, Augustin M, Blome C, Forschner A, Garbe C, Gutzmer R, Hauschild A, et al. Journal article Can checkpoint inhibitor therapy improve response to chemotherapy? (2018) Kirchberger MC, Schilling B, Haferkamp S, Boßerhoff AK, Schuler G, Heinzerling L Journal article Managing toxicities of immunotherapies - a side effect register for rare and severe side effects of checkpoint Inhibitor therapy (2018) Heinzerling L, Schuler G Conference contribution Effective anti-programmed death-1 therapy in a SUFU-mutated patient with Gorlin-Goltz syndrome (2018) Moreira A, Kirchberger MC, Toussaint F, Erdmann M, Schuler G, Heinzerling L Journal article Clinical outcome of concomitant vs interrupted BRAF inhibitor therapy during radiotherapy in melanoma patients (2018) Hecht M, Meier F, Zimmer L, Polat B, Loquai C, Weishaupt C, Forschner A, et al. Journal article